共 35 条
[1]
Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1998, 280 (11)
:975-980
[2]
LONG-TERM SURVIVAL AMONG MEN WITH CONSERVATIVELY TREATED LOCALIZED PROSTATE-CANCER
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1995, 274 (08)
:626-631
[4]
TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC)
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1995, 31 (05)
:1341-1346
[5]
Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
[6]
Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2004, 60 (03)
:777-787
[10]
HANKS GE, 1994, CANCER, V74, P2174, DOI 10.1002/1097-0142(19941001)74:7+<2174::AID-CNCR2820741729>3.0.CO